Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
63.76
-0.27 (-0.42%)
Apr 29, 2026, 3:00 PM CST
89.82% (1Y)
| Market Cap | 11.16B |
| Revenue (ttm) | 1.35B |
| Net Income (ttm) | 274.30M |
| Shares Out | 174.35M |
| EPS (ttm) | 1.58 |
| PE Ratio | 40.51 |
| Forward PE | 36.80 |
| Dividend | 0.43 (0.65%) |
| Ex-Dividend Date | Jun 11, 2025 |
| Volume | 1,466,330 |
| Average Volume | 3,993,175 |
| Open | 64.08 |
| Previous Close | 64.03 |
| Day's Range | 62.70 - 64.98 |
| 52-Week Range | 32.55 - 80.48 |
| Beta | 0.14 |
| RSI | 46.56 |
| Earnings Date | Apr 22, 2026 |